Aptevo Therapeutics (APVO) Return on Invested Capital (2016 - 2017)
Aptevo Therapeutics (APVO) posted Return on Invested Capital of 4.01% for Q2 2017, down 35.39% sequentially from 2.96% in Q1 2017, and down 296.0% YoY from 2.04% in Q2 2016.
Aptevo Therapeutics (APVO) Return on Invested Capital (2016 - 2017) Analysis & Trends
Aptevo Therapeutics has reported Return on Invested Capital for 2 years, with the latest figure at 4.01% in Q2 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.04% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -0.17% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.35% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Aptevo Therapeutics | 3.18 Mn | -6.61 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2017 | -4.01% |
| Mar 31, 2017 | -2.96% |
| Dec 31, 2016 | -1.88% |
| Sep 30, 2016 | -1.61% |
| Jun 30, 2016 | -1.05% |